<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="hpja910" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Health Promot J Austr</journal-id><journal-id journal-id-type="iso-abbrev">Health Promot J Austr</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">HPJA</journal-id><journal-title-group><journal-title>Health Promotion Journal of Australia</journal-title></journal-title-group><issn pub-type="ppub">1036-1073</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11730269</article-id><article-id pub-id-type="pmcid-ver">PMC11730269.1</article-id><article-id pub-id-type="pmcaid">11730269</article-id><article-id pub-id-type="pmcaiid">11730269</article-id><article-id pub-id-type="pmid">39223443</article-id><article-id pub-id-type="doi">10.1002/hpja.910</article-id><article-id pub-id-type="publisher-id">HPJA910</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Pharmacist E&#8208;script transcription service initiated nicotine replacement therapy uptake in pre&#8208;admission clinic: A pilot study</article-title><alt-title alt-title-type="left-running-head">Meanger et al.</alt-title></title-group><contrib-group><contrib id="hpja910-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Meanger</surname><given-names initials="D">Darshana</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-1172-5973</contrib-id><xref rid="hpja910-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>darshana.meanger@easternhealth.org.au</email></address></contrib><contrib id="hpja910-cr-0002" contrib-type="author"><name name-style="western"><surname>Webb</surname><given-names initials="A">Ashley</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9037-158X</contrib-id><xref rid="hpja910-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hpja910-cr-0003" contrib-type="author"><name name-style="western"><surname>Banakh</surname><given-names initials="I">Iouri</given-names></name><xref rid="hpja910-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="hpja910-cr-0004" contrib-type="author"><name name-style="western"><surname>Coward</surname><given-names initials="L">Lisa</given-names></name><xref rid="hpja910-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hpja910-cr-0005" contrib-type="author"><name name-style="western"><surname>Cripps</surname><given-names initials="G">Gael</given-names></name><xref rid="hpja910-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="hpja910-cr-0006" contrib-type="author"><name name-style="western"><surname>George</surname><given-names initials="J">Johnson</given-names></name><xref rid="hpja910-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="hpja910-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Peninsula Health Pharmacy Department and Eastern Health Pharmacy Department</named-content>
<institution>Frankston Hospital</institution>
<city>Frankston</city>
<country country="AU">Australia</country>
</aff><aff id="hpja910-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Peninsula Health Anaesthetics Department</named-content>
<institution>Frankston Hospital</institution>
<city>Frankston</city>
<country country="AU">Australia</country>
</aff><aff id="hpja910-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Monash Health Pharmacy Department</named-content>
<institution>Frankston Hospital</institution>
<city>Frankston</city>
<country country="AU">Australia</country>
</aff><aff id="hpja910-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Peninsula Health Preadmission Clinic</named-content>
<institution>Frankston Hospital</institution>
<city>Frankston</city>
<country country="AU">Australia</country>
</aff><aff id="hpja910-aff-0005">
<label>
<sup>5</sup>
</label>
<institution>Centre for Medicine Use and Safety, Monash University</institution>
<city>Frankston</city>
<country country="AU">Australia</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Darshana Meanger, Maroondah Hospital Pharmacy Department 1/15 Davey Dr, Ringwood East VIC 3135, Australia.<break/>
Email: <email>darshana.meanger@easternhealth.org.au</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2025</year></pub-date><volume>36</volume><issue seq="560">1</issue><issue-id pub-id-type="pmc-issue-id">479466</issue-id><issue-id pub-id-type="doi">10.1002/hpja.v36.1</issue-id><elocation-id>e910</elocation-id><history><date date-type="rev-recd"><day>03</day><month>7</month><year>2024</year></date><date date-type="received"><day>19</day><month>9</month><year>2023</year></date><date date-type="accepted"><day>23</day><month>7</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>01</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>15</day><month>01</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-28 17:25:14.320"><day>28</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2024 The Author(s). <italic toggle="yes">Health Promotion Journal of Australia</italic> published by John Wiley &amp; Sons Australia, Ltd on behalf of Australian Health Promotion Association.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="HPJA-36-0.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:HPJA-36-0.pdf"/><abstract><title>Abstract</title><sec id="hpja910-sec-0001"><title>Background</title><p>Pharmacist&#8208;led smoking cessation programs in pre&#8208;admission clinics (PAC) have shown to increase quit attempts and achieve abstinence by the day of surgery (DOS).</p></sec><sec id="hpja910-sec-0002"><title>Aims</title><p>To evaluate the feasibility of Pharmacist E&#8208;script Transcription Service (PETS) initiated nicotine replacement therapy (NRT) in PAC, including smoking cessation on DOS.</p></sec><sec id="hpja910-sec-0003"><title>Methods</title><p>A single centre, pre and post&#8208;intervention pilot study conducted at an Australian public hospital PAC. In a two&#8208;month intervention period, PAC nursing staff invited smokers (&#8805;1 cigarette/day) to see a smoking cessation PET pharmacist. Pharmacist&#8208;initiated NRT and Quitline&#169; referrals were offered. Cessation outcomes were compared with the preceding two&#8208;month control period. Primary outcome: feasibility of intervention. Secondary outcomes: DOS smoking abstinence rates and three&#8208;months post&#8208;surgery.</p></sec><sec id="hpja910-sec-0004"><title>Results</title><p>PAC nurses identified 112 smokers over 4&#8201;months; 53 during pre&#8208;intervention period, and 59 during intervention period. Twenty&#8208;two intervention patients (37%) accepted seeing the pharmacist, with 16 subsequent Quitline&#169; referrals (73%) and 11 NRT prescriptions (50%) written. The median nursing smoking status documentation time increased in the intervention period (1&#8201;min vs. 4, <italic toggle="no">p</italic>&#8201;&lt;&#8201;.001). The intervention did not impact pharmacist's workload. Verified abstinence increased from 8.5% (4/47) pre&#8208;intervention to 9.4% (5/53) post&#8208;intervention, <italic toggle="no">p</italic>&#8201;=1.00. Relapse rates in the intervention period increased (20% vs. 50%) at three&#8208;months post&#8208;surgery.</p></sec><sec id="hpja910-sec-0005"><title>Conclusion</title><p>A PETS&#8208;initiated NRT program in PAC is feasible and increased preoperative use of NRT and Quitline&#169; with minimal impact on smoking cessation.</p></sec><sec id="hpja910-sec-0006"><title>So what?</title><p>This study has highlighted the importance of implementing a multidisciplinary smoking cessation program in PAC however, larger studies are needed to determine the true impact of the program on smoking cessations.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="hpja910-kwd-0001">abstinence</kwd><kwd id="hpja910-kwd-0002">nicotine replacement</kwd><kwd id="hpja910-kwd-0003">pharmacist</kwd><kwd id="hpja910-kwd-0004">pre&#8208;admission clinic</kwd><kwd id="hpja910-kwd-0005">smoking cessation</kwd></kwd-group><counts><fig-count count="1"/><table-count count="4"/><page-count count="8"/><word-count count="4600"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.2 mode:remove_FC converted:13.01.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="hpja910-cit-9001"><string-name name-style="western"><surname>Meanger</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Webb</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Banakh</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Coward</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cripps</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>George</surname><given-names>J</given-names></string-name>. <article-title>Pharmacist E&#8208;script transcription service initiated nicotine replacement therapy uptake in pre&#8208;admission clinic: A pilot study</article-title>. <source>Health Promot J Austral</source>. <year>2025</year>;<volume>36</volume>(<issue>1</issue>):<elocation-id>e910</elocation-id>. <pub-id pub-id-type="doi">10.1002/hpja.910</pub-id><pub-id pub-id-type="pmcid">PMC11730269</pub-id><pub-id pub-id-type="pmid">39223443</pub-id></mixed-citation>
</p><fn-group id="hpja910-ntgp-0001"><fn id="hpja910-note-0001"><p>Address the study was conducted: Frankston Hospital, 2 Hastings Road Frankston Hospital VIC 3199, Australia.</p></fn><fn id="hpja910-note-0002"><p>
<bold>Handling editor:</bold> Mark Robinson</p></fn></fn-group></notes></front><body id="hpja910-body-0001"><sec id="hpja910-sec-0007"><label>1</label><title>INTRODUCTION</title><p>Smoking increases risks of post&#8208;surgical complications, including post&#8208;operative wound infections and respiratory complications; on the other hand, pre&#8208;operative quitting for 4&#8211;8&#8201;weeks significantly decreases these risks.<xref rid="hpja910-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="hpja910-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>
</p><p>Several studies of smoking cessation interventions in pre&#8208;operative clinics have been published, with most providing behavioural counselling and/or nicotine replacement therapy (NRT).<xref rid="hpja910-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="hpja910-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="hpja910-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="hpja910-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> While pre&#8208;admission clinics (PAC) were shown to be feasible locations for offering smoking cessation interventions, with up to 60% of smokers accepting help, many of the published studies utilised resource intensive, high intensity interventions that may lack feasibility in routine clinical practices.<xref rid="hpja910-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="hpja910-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Programs that utilise existing and funded services such as Quitline&#169; and the Pharmaceutical Benefits Scheme (PBS) to reduce perioperative smoking are more likely to be implemented in resource constrained health system. In 2023 the general patient cost of 28 21&#8201;mg/h nicotine patches under the PBS was $30 compared to the non&#8208;subsidised cost of $60.<xref rid="hpja910-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="hpja910-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Smoking cessation best practice involves behavioural support in combination with pharmacotherapy.<xref rid="hpja910-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Quitline&#169; is a free call&#8208;back behavioural support service and is a pre&#8208;requisite for subsidised NRT prescriptions; NRT prescription recipients are asked to enrol in Quitline&#169;.<xref rid="hpja910-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>
</p><p>Pharmacist&#8208;led smoking cessation interventions have shown to be effective in achieving both short&#8208; and long&#8208;term abstinence in pre&#8208;operative, hospital inpatient and rehabilitation settings.<xref rid="hpja910-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="hpja910-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="hpja910-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="hpja910-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Additionally, many health services have established Pharmacist E&#8208;script Transcription Service (PETS) or similar services with trained pharmacists to co&#8208;prescribe/transcribe discharge prescriptions. While prescriptions are required to be co&#8208;signed by the treating doctor, the PETS model has been shown to facilitate the discharge process and reduce prescribing errors.<xref rid="hpja910-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Utilisation of this PETS model to increase provision of PBS prescriptions of NRT to outpatients is novel and may reduce existing barriers to the uptake of NRT in the PAC,<xref rid="hpja910-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> such as lack of time or knowledge of NRT prescribing by junior medical staff.</p><p>This study evaluated the feasibility of a PETS&#8208;initiated NRT program in PAC and compared the effects on smoking abstinence rates by day of surgery (DOS) against standard care in a smoke&#8208;free public hospital.</p></sec><sec sec-type="methods" id="hpja910-sec-0008"><label>2</label><title>METHODS</title><sec id="hpja910-sec-0009"><label>2.1</label><title>Setting and participants</title><p>Single centre, pre&#8208; and post&#8208;interventional pilot study at Frankston Hospital PAC, a smoke&#8208;free tertiary care public hospital in Victoria, Australia. The study included all adult elective surgery patients attending Frankston Hospital PAC (March&#8211;June 2021) who self&#8208;reported being current smokers (&#8805;1 cigarette/day). Exclusion criteria were inability to communicate in English, understand study requirements, surgery dates scheduled for the weekend or at a private hospital (due to lack of data collector availability).</p></sec><sec id="hpja910-sec-0010"><label>2.2</label><title>Study design/intervention</title><p>Patients in the two&#8208;month standard care group (pre&#8208;intervention period) received no systematic smoking cessation pharmacotherapy or Quitline&#169; support in PAC. Pre&#8208;intervention, patients attending PAC saw a variety of different clinicians (nurses/surgical residents or registrars/anaesthetist/physiotherapist/pharmacist) with no single clinician having primary responsibility to address patient smoking and provide cessation advice/help. Smoking cessation brochures were available in PAC, but provision was variable depending on clinician. Pharmacist in the pre&#8208;intervention period only had capacity to see high risk peri&#8208;operative patients due to limited resources.</p><p>Prior to the two&#8208;month intervention period, pharmacists and PAC nurses undertook free online Quit Victoria &#8216;Brief advice training&#8217; to improve counselling skills.<xref rid="hpja910-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> During the intervention period, PAC nurses systemically documented smoking status, provided structured quit smoking advice before surgery and invited patients to see a PETS PAC pharmacist for further cessation assistance. Those agreeing for pharmacist consultation were offered a Quitline&#169; referral. Participants that signed up to Quitline&#169; were offered a pharmacist generated PBS prescription for NRT (unless contraindicated).</p><p>Pharmacists prescribed NRT electronically (CernerCorp, North Kansas City, USA) using pre&#8208;populated &#8216;Power Plans&#8217;, according to patient's nicotine dependence (low, medium, or high). As standard practice, the PETS NRT prescriptions were later co&#8208;signed by surgical staff. Smokers were advised to consult their general practitioner (GP) or community pharmacist for additional NRT beyond the initial script. PAC nurses systematically provided the Peninsula Health &#8216;Stop Smoking&#8217; leaflet to all PAC smokers.</p><p>On DOS (prior to operation), cessation data was collected by researchers using a structured questionnaire. If claiming quit &gt;24&#8208;h, verification with carbon monoxide (CO) breath testing (quit &#8804;8 parts&#8208;per&#8208;million (ppm)) was requested and quit patients were telephoned three&#8208;months post&#8208;discharge to determine smoking relapse. Those who refused a CO breath testing or those showing &gt;8&#8201;ppm was classified as current smoker.<xref rid="hpja910-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Seven&#8208;day point prevalence was collected to account for those that had less than 7&#8201;days to quit due to their PAC appointment being close to their surgery.</p></sec><sec id="hpja910-sec-0011"><label>2.3</label><title>Consent</title><p>Research assistance obtained a verbal consent to undertake the DOS survey and a written consent for a CO breath test and three&#8208;month follow up.</p></sec><sec id="hpja910-sec-0012"><label>2.4</label><title>Measures and tools</title><p>Acceptability was measured as the proportion of patients agreeing to see the pharmacist after invitation by PAC nursing staff, and the rate of patients agreeing to NRT/Quitline&#169; prescription by the pharmacist. Number of Quitline&#169; contacts by DOS and at three&#8208;months was also collected during participant follow up.</p><p>Heaviness of smoking index (HSI) score is a scoring tool that utilises two questions from the Fagerstrom Test for Nicotine Dependence (time to first cigarette and number smoked per day).<xref rid="hpja910-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="hpja910-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> The HSI score ranges from 0 to 6 (low (0&#8211;1), medium (2&#8211;4) or high (5&#8208;6)). All patients' HSI scores were assessed at PAC and on the DOS.<xref rid="hpja910-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>
</p><p>Naranjo Algorithm is an Adverse Drug Reaction (ADR) probability scale that assesses if the ADR has a causal relationship to the suspected treatment.<xref rid="hpja910-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> This scale was utilised as part of the DOS interview when assessing NRT related ADRs.</p><p>Visual analogue scale (VAS) was used to measure the patients' level of confidence and motivation to quit smoking. This 10&#8208;point numerical scale ranges from zero for &#8216;not motivated or confident&#8217; to 10 for &#8216;very motivated or confident&#8217;.<xref rid="hpja910-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>
</p></sec><sec id="hpja910-sec-0013"><label>2.5</label><title>Outcome measures</title><p>
<list list-type="order" id="hpja910-list-0001"><list-item id="hpja910-li-0001"><p>Primary outcome measures for feasibility were acceptability (percentage that accepted the intervention), demand (percentage eligible to see the pharmacist and for a NRT prescription), implementation (change in PAC workflow), practicality (time taken for nurses to address smoking cessation and number of patients seen by the pharmacist) and adaptation (percentage of PAC staff who underwent Quitline&#169; training and education).</p></list-item><list-item id="hpja910-li-0002"><p>Secondary outcome measures were abstinence rates (quit for &gt;24&#8201;h with a CO level of &#8804;8&#8201;ppm), self&#8208;reported reduction in smoking, reduction in HSI scores by the DOS, &gt;&#8201;7&#8201;day quit rates, NRT and Quitline&#169; uptake and abstinence at three&#8208;months post&#8208;surgery in both periods.</p></list-item></list>
</p></sec><sec id="hpja910-sec-0014"><label>2.6</label><title>Statistical analysis</title><p>Data analysis was performed using Statistical Package for Social Sciences (SPSSversion 25). Mann&#8211;Whitney U tests were used to compare feasibility outcomes pre and post&#8208;intervention (time taken for PAC staff to complete data collection sheets and the number of patients seen by the pharmacist in PAC). The standard deviation of the mean times of each nurse in the pre&#8208;intervention period was calculated to determine the variability in the time taken to address smoking cessation between the nurses. Those who declined to be followed&#8208;up on the DOS were treated as lost to follow up and were excluded from the analysis. Fisher's exact test was used to analyse DOS secondary outcomes including self&#8208;reports of abstinence, biochemically verified self&#8208;reports of abstinence, reduction in HSI score as well as continuous abstinence at three&#8208;months post&#8208;surgery. Those that refused to undertake the CO breath test on the DOS were treated as smoking abstinence failures and were included in the final analysis. An unpaired student <italic toggle="yes">t</italic>&#8208;test was used to analyse continuous data (e.g., age) and a Chi&#8208;square test was used to analyse categorical data (e.g., sex, level of nicotine dependency and category of surgery). Categories of surgeries were defined based on the urgency of the surgery (category 1 within 30&#8201;days, category 2 within 90&#8201;days and category 3 within a year). A sample size calculation was not undertaken given that it was a pilot study to determine feasibility of the intervention.</p></sec></sec><sec sec-type="results" id="hpja910-sec-0015"><label>3</label><title>RESULTS</title><p>A total of 640 patients were scheduled to attend the PAC between March to July 2021, of which 582 patients were screened for study eligibility (Figure&#160;<xref rid="hpja910-fig-0001" ref-type="fig">1</xref>). Fifty&#8208;eight patients were not screened due to failed appointment attendance or incomplete data collection sheets. Eight patients were lost to follow&#8208;up on the DOS due to either the COVID&#8208;19 pandemic, weekend surgery dates, private hospital admission or missed by researchers.</p><fig position="float" fig-type="FIGURE" id="hpja910-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Patient flow.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="HPJA-36-0-g001.jpg"/></fig><p>The population screened had a 19.2% (112/582) smoking rate with 53 patients in the pre&#8208;intervention group and 59 patients in the intervention group (Figure&#160;<xref rid="hpja910-fig-0001" ref-type="fig">1</xref>). Patient characteristics were overall similar in both periods, but there were more category 3 and orthopaedic surgeries in the pre&#8208;intervention group, while urgent general surgery were more frequent in the intervention group (Table&#160;<xref rid="hpja910-tbl-0001" ref-type="table">1</xref>).</p><table-wrap position="float" id="hpja910-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Baseline characteristics of participants.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristics</th><th align="left" valign="bottom" rowspan="1" colspan="1">Pre&#8208;intervention (<italic toggle="yes">n</italic>&#8201;=&#8201;53)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Intervention (<italic toggle="yes">n</italic>&#8201;=&#8201;59)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#8208;Value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Female</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>25 (47%)</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">25 (42%)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.704</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Male</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">28 (53%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>34 (58%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.610</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age mean in years (SD)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>62.8 (11.8)</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">59.6 (12.6)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.303</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Surgery category</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cat 1</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">21 (40%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>22 (37%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.847</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cat 2</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">17 (32%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>33 (56%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>.014</bold>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cat 3</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>15 (28%)</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4 (7.0%)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>.005</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pension card</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>36 (68%)</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">34 (58%)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.329</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HSI score</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Low (0&#8211;2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">31 (58%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>40 (68%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.332</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Medium (4&#8208;3)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>20 (38%)</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">17 (29%)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.421</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">High (5, 6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>2 (4.0%)</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2 (3.0%)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.912</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PAC to OT time</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&lt;&#8201;7&#8201;days</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">14 (26%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>16 (27%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.933</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">7&#8211;32&#8201;days</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">29 (55%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>33 (56%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.897</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&gt;&#8201;32&#8201;days</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>10 (19%)</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">10 (17%)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.810</td></tr></tbody></table><table-wrap-foot id="hpja910-ntgp-0002"><fn id="hpja910-note-0111"><p>
<italic toggle="yes">Note</italic>: Bold indicates a higher comparative number.</p></fn><fn id="hpja910-note-0004"><p>Abbreviations: HSI, Heaviness of Smoking Index; OT, operating theatre; PAC, Pre&#8208;admission clinic; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><sec id="hpja910-sec-0016"><label>3.1</label><title>Primary outcomes</title><p>In the intervention period 39% (23/59) patients agreed to see the pharmacist, with one low dependency patient refusing to wait for the pharmacist. Accepted patients were highly motivated to quit (median score of 8 (IQR =3)) and confident of success (median score of 7 (IQR&#8201;=&#8201;4)) but high levels of nicotine dependence were uncommon (Table&#160;<xref rid="hpja910-tbl-0002" ref-type="table">2</xref>). Out of the 22 patients, 16 (72%) were signed up to Quitline&#169; and 11 (50%) requested and were generated a PETS NRT prescription. Three patients were ineligible for NRT prescription as they were already using stop smoking medications or products (e&#8208;cigarettes and NRT) at the time of their PAC appointment.</p><table-wrap position="float" id="hpja910-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Characteristics of patients who accepted to see the pharmacist.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristics of acceptors</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic>&#8201;=&#8201;22<xref rid="hpja910-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Level of dependency (HSI score)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Low (0&#8211;2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">9 (40%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Medium (4, 5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">12 (52%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">High (5, 6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1 (4.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Motivation to quit</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Low (0&#8211;5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2 (9%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">High (6&#8211;10)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">20 (91%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Confidence to quit</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Low (0&#8211;5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">7 (32%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">High (6&#8211;10)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">15 (68%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NRT prescribed</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Patch</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">5 (23%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Lozenge</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2 (9%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Combination</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4 (18%)</td></tr></tbody></table><table-wrap-foot id="hpja910-ntgp-0003"><fn id="hpja910-note-0005"><label>
<sup>a</sup>
</label><p>Minus one acceptor who did not wait to see the pharmacist (Total 23 acceptors).</p></fn></table-wrap-foot></table-wrap><p>Three reports of workflow issues and one report of prescription signage delay were identified. As expected, nursing staff spent more time discussing smoking cessation in the post&#8208;intervention period then the pre&#8208;intervention period (Table&#160;<xref rid="hpja910-tbl-0003" ref-type="table">3</xref>). Smoking status documentation improved from pre&#8208; to post&#8208;intervention through completing of the PAC tobacco cessation tool. Pharmacists in the pre&#8208;intervention period only had capacity to see high&#8208;risk peri&#8208;operative patients due to limited resources.</p><table-wrap position="float" id="hpja910-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Time taken by nursing staff and number of patients seen by the pharmacist in PAC.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Measures</th><th align="left" valign="bottom" rowspan="1" colspan="1">Pre&#8208;intervention</th><th align="left" valign="bottom" rowspan="1" colspan="1">Intervention</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#8208;Value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">PAC nursing staff time taken in minutes (median (IQR))</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.0 (1.0)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4.5 (3.0)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No. of patients seen by the pharmacist (median (IQR))</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">6.0 (3.0)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">6.0 (2.0)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot id="hpja910-ntgp-0004"><fn id="hpja910-note-0007"><p>Abbreviations: IQR, Interquartile range; OT, operating theatre; PAC, Pre&#8208;admission Clinic.</p></fn></table-wrap-foot></table-wrap><p>The workload of the pharmacist was not increased by the intervention deeming the intervention feasible (Table&#160;<xref rid="hpja910-tbl-0003" ref-type="table">3</xref>).</p></sec><sec id="hpja910-sec-0017"><label>3.2</label><title>Secondary outcome</title><p>Biochemically (CO breath test)&#8208;verified self&#8208;reported abstinence rates slightly improved pre and post&#8208;intervention (4/47 vs. 5/53) however self&#8208;reported abstinence rates doubled from 8.5% (4/47) in the pre&#8208;intervention period to 18.9% (10/53) in the post&#8208;intervention period (<italic toggle="yes">p</italic>&#8201;=&#8201;.152) (Table&#160;<xref rid="hpja910-tbl-0004" ref-type="table">4</xref>). One patient in the post&#8208;intervention period recorded a CO level of 25&#8201;ppm. Seventy&#8208;one percent (38/53) of patients in the post&#8208;intervention group self&#8208;reported to have cut down by the DOS compared to 64% (30/47) in the pre&#8208;intervention group (<italic toggle="yes">p</italic>&#8201;=&#8201;.520). A larger number of patients with a reduction in their HSI score on the DOS was seen in the post&#8208;intervention group (Table&#160;<xref rid="hpja910-tbl-0004" ref-type="table">4</xref>).</p><table-wrap position="float" id="hpja910-tbl-0004" content-type="TABLE" orientation="portrait"><label>TABLE 4</label><caption><p>DOS smoking characteristics.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1">Measures</th><th colspan="3" align="left" valign="bottom" rowspan="1">All patients</th><th colspan="3" align="left" valign="bottom" rowspan="1">Seen by pharmacist</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Pre&#8208;intervention (<italic toggle="yes">N</italic>&#8201;=&#8201;47)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Post&#8208;intervention (<italic toggle="yes">N</italic>&#8201;=&#8201;53)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>&#8208;Value</th><th align="left" valign="bottom" rowspan="1" colspan="1">Pre&#8208;intervention (<italic toggle="yes">N</italic>&#8201;=&#8201;20)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Post&#8208;intervention (<italic toggle="yes">N</italic>&#8201;=&#8201;22)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>&#8208;Value</th></tr></thead><tbody valign="top"><tr><td colspan="7" align="left" valign="top" rowspan="1">Self&#8208;reported DOS quit rates</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">7&#8201;day point prevalence</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2 (4.2%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>3 (5.7%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.000</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1 (5.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>2 (9.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&lt;&#8201;7&#8201;day point prevalence</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2 (4.2%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>7 (13.2%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.162</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0 (.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>3 (13.6%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.233</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Total</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4 (8.5%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>10 (18.9%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.152</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1 (5.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>5 (22.7%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.187</td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1">Biochemically verified DOS quit rates</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">7&#8201;day point prevalence</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>2 (4.2%)</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2 (3.8%)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.000</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>1 (5.0%)</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1 (4.5%)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&lt;&#8201;7&#8201;day point prevalence</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2 (4.2%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>3 (5.7%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.000</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0 (0.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>1 (4.5%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Total</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4 (8.5%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>5 (9.4%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.000</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1 (5.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>2 (9.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1">DOS smoking characteristics</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Self&#8208;report cut down</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">30 (63.8%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>38 (71.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.520</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">15 (75.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">15 (68.0%)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.738</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Reduction in HSI score</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">11 (23.4%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>15 (28.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.651</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">3 (15.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>8 (36.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.165</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">No. using NRT</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">12 (25.5%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>19 (34.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.287</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">7 (35.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>10 (45.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.543</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">No. contacted quitline</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4 (8.5%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>14 (26.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.035</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1 (5.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>10 (45.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.004</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Perioperative quit attempt (ended in relapsed)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4 (8.5%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>8 (15.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.368</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1 (5.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>2 (9.1%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Using stop smoking medications</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">16 (34.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>20 (38.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.835</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">8 (40.0%)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">
<bold>10 (45.0%)</bold>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">.764</td></tr></tbody></table><table-wrap-foot id="hpja910-ntgp-0104"><fn id="hpja910-note-0112"><p>
<italic toggle="yes">Note</italic>: Bold indicates a higher comparative number.</p></fn><fn id="hpja910-note-0107"><p>Abbreviations: DOS, Day of Surgery; HSI, Heaviness Smoking Index; NRT, Nicotine Replacement.</p></fn></table-wrap-foot></table-wrap><p>DOS NRT use (34% vs. 25.5%) and Quitline&#169; contact (26% versus 8.5%) was higher in the post&#8208;intervention group compared to the pre&#8208;intervention group (Table&#160;<xref rid="hpja910-tbl-0004" ref-type="table">4</xref>). One patient given an NRT lozenge prescription experienced an ADR (heart racing).</p><p>Post&#8208;operative relapse to smoking was common with two of the four verified quitters in the pre&#8208;intervention group (50%) and four of the five verified quitters (80%) in the intervention period relapsing. NRT use remained high in the intervention group post&#8208;surgery (80% [4/5] vs. 25% [1/4], respectively, <italic toggle="yes">p</italic>&#8201;=&#8201;.206).</p></sec></sec><sec sec-type="discussion" id="hpja910-sec-0018"><label>4</label><title>DISCUSSION</title><p>Smoking cessation interventions in PAC such as the PETS initiated NRT program is feasible to implement and affordable when leveraging off existing funded programs such as the PBS and Quitline&#169;. This pilot study of a pharmacist&#8208;led smoking cessation program in PAC demonstrated some favourable trends such as: increase in NRT uptake and reduction in HSI scores but did not change biochemically verified abstinence.</p><p>With acceptance rates mostly compromising of low to moderate nicotine dependent participants this study further highlights the ongoing difficulty in engaging high dependency smokers due to minimal motivation and confidence to quit in these settings. This indicates that &#8216;brief&#8217; perioperative smoking cessation advice may not be enough for high dependency smokers. Close to half of the patients who accepted to see the pharmacist in intervention period were of low dependency, for whom nicotine replacement therapy is not necessarily needed. Highlighting that future models of care could consider having nursing staff manage low dependency patents, allowing the pharmacist to maintain their focus on moderate&#8208;high dependency patients. Interestingly, a larger number of patients reported to be using NRT on the DOS in the post&#8208;intervention period than prescribed in the PAC, highlighting that just the conversation in PAC may influence NRT uptake before the DOS.</p><p>Three in five patients refused seeking pharmacist assistance for smoking cessation support, despite impending surgery. Acceptance rates of the intervention were like other studies that offered behavioural support and NRT.<xref rid="hpja910-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> However, most studies provided free pharmacotherapy which may not be feasible and/or did not have a pharmacist&#8208;led model of care.<xref rid="hpja910-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="hpja910-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="hpja910-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="hpja910-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="hpja910-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="hpja910-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Surgeon&#8208;led interventions have shown to increase the desire to quit before surgery.<xref rid="hpja910-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Patient pharmacist acceptance rates for smoking cessation support could be increased through referrals from other health professionals in PAC such as doctors, an &#8216;opt out&#8217; not &#8216;opt in&#8217; to see the pharmacist process or use of CO breath tests to increase interest in quitting.</p><p>This study demonstrated similar improvement in self&#8208;reported abstinence rates by the DOS compared to other studies.<xref rid="hpja910-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> However studies such as Lee et al had shown a greater improvement in biochemically verified self&#8208;reported abstinence rates, potentially due to a higher CO level cut off (&lt;10&#8201;ppm versus &lt;8&#8201;ppm).<xref rid="hpja910-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> The study showed that patients who were seen by the pharmacist in PAC were more likely to have self&#8208;reported abstinence, NRT use and Quitline&#169; uptake. The difference between self&#8208;reported smoking reduction rates pre&#8208; and post&#8208;intervention in those who had been seen by the pharmacist were better than that of Lee et al (20.6% versus 32.5%); however, the results failed to achieve statistical significance.<xref rid="hpja910-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>
</p><p>The study had a much higher relapse rate at three&#8208;months post&#8208;surgery despite an increase in NRT/Quitline&#169; use. Possibly due to an increase in stressors during the COVID pandemic and lack of motivation to quit for life. Suggesting that newly quit smokers may need more support post&#8208;surgery to encourage continuous abstinence such as &#8216;relapse packs&#8217; offered by Web et al.<xref rid="hpja910-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>
</p><sec id="hpja910-sec-0019"><label>4.1</label><title>Strengths and limitations</title><p>The study used a novel multidisciplinary structured pharmacist&#8208;led smoking cessation program, which utilised the RACGP recommended AAH model of care and Quitline&#169; behavioural support.<xref rid="hpja910-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> This model of care can be easily implemented into any healthcare system, given the use of PBS to minimise any additional funding requirements. This study expanded the scope of pharmacists and has shown that a pharmacist&#8208;led model of care can be feasible for larger, future studies.</p><p>The study's major limitation was the intervention's implementation during the COVID&#8208;19 lockdowns leading to a major difference in the pre&#8208;post period. This led to changes in categories and types of surgeries between the two study periods due to changes in elective surgery criteria. Furthermore, the COVID&#8208;19 outbreak may have discouraged patients from considering quitting given the added stressors leading to a decline in acceptance rates during this period and an increase in smoking relapse rates at three&#8208;months post&#8208;surgery in the post intervention period. However, the study did not capture the confidence data in the pre&#8208;intervention period therefore there is no way to verify this. Despite the excess demands on the hospital during the COVID&#8208;19 lockdown, the pharmacists saw a similar number of patients as the pre&#8208;intervention period, highlighting the intervention model's viability. Other limitations of the study included the single&#8208;centre and non&#8208;parallel study design, which may have resulted in selection bias. Group sizes were small and most patients who had accepted the invitation to see the pharmacist were very confident and motivated to quit. Baseline group characteristics were similar, although there was a small difference in nicotine dependence, which may have had an impact on overall quit rates.</p><p>Self&#8208;reports may have led to social desirability bias when responding to questions. CO breath test was utilised to biochemically verify self&#8208;reports on the DOS to objectively verify self&#8208;reported abstinence. However, biochemical verification was not possible at three&#8208;month follow up due to limited resources. Lastly, the HSI score can have a floor effect amongst light smokers which may impact the validity of the tool in this population. HSI score does not consider the number of quit attempts which if taken into account could alter the number of participants who were of &#8216;low nicotine dependence&#8217;.</p></sec></sec><sec sec-type="conclusions" id="hpja910-sec-0020"><label>5</label><title>CONCLUSION</title><p>A PETS initiated NRT program in PAC is a novel cost effective and feasible initiative that led to increased perioperative NRT uptake, increase Quitline&#169; use, reduce nicotine dependency, and minor improvement in quit rates. The program has now been implemented into routine presurgical care. Further studies are needed to quantify the improvement in abstinence rates by the DOS observed; Economic evaluation of the intervention will be valuable to inform resource allocation and policy making. In addition, there is a gap in research involving pharmacist&#8208;led models of care in a preoperative clinic setting and more studies are needed to be able to determine true effect on both short and long&#8208;term abstinence of such a model in clinical practice. This study has highlighted the importance of implementing a multidisciplinary smoking cessation program in PAC to encouraging elective surgery patients to begin their quit journey.</p></sec><sec sec-type="COI-statement" id="hpja910-sec-0022"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare no conflicts of interest.</p></sec><sec id="hpja910-sec-0025"><title>ETHICS STATEMENT</title><p>The Peninsula Health Research Ethics Committee approved the study and waived the requirement for consent by participating patients (HREC/70155/PH&#8208;2020).</p></sec></body><back><ack id="hpja910-sec-0021"><title>ACKNOWLEDGEMENTS</title><p>We thank heads of Department, Nicholas Jones (Pharmacy) and Chris Bowden (Anaesthesia) study support. We thank all PAC nursing staff and pharmacists, Monash University medical students' for data collection and Dr Daniel J McDonald for reviewing the study protocol and manuscript. This manuscript was not funded. Open access publishing facilitated by Monash University, as part of the Wiley &#8208; Monash University agreement via the Council of Australian University Librarians.</p></ack><sec sec-type="data-availability" id="hpja910-sec-0024"><title>DATA AVAILABILITY STATEMENT</title><p>The data supporting the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p></sec><ref-list id="hpja910-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="hpja910-bib-0001"><label>1</label><mixed-citation publication-type="book" id="hpja910-cit-0001"><string-name name-style="western"><surname>Yoong</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Tursan d'Espaignet</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Wiggers</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>St Claire</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mellin&#8208;Olsen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Grady</surname><given-names>A</given-names></string-name>, et al. <source>WHO tobacco knowledge summaries: tobacco and postsurgical outcomes</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organiza on</publisher-name>; <year>2020</year> Licence: CC BY&#8208;NC&#8208;SA 3.0 IGO.</mixed-citation></ref><ref id="hpja910-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="hpja910-cit-0002"><string-name name-style="western"><surname>Thomsen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Villebro</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>M&#248;ller</surname><given-names>AM</given-names></string-name>. <article-title>Interventions for preoperative smoking cessation</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2014</year> Mar 27;<volume>2014</volume>(<issue>3</issue>):<fpage>CD002294</fpage>.<pub-id pub-id-type="pmid">24671929</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD002294.pub4</pub-id><pub-id pub-id-type="pmcid">PMC7138216</pub-id></mixed-citation></ref><ref id="hpja910-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="hpja910-cit-0003"><string-name name-style="western"><surname>Sachs</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Wild</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hammal</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Finegan</surname><given-names>B</given-names></string-name>. <article-title>Smoking cessation interventions in the pre&#8208;admission clinic: assessing two approaches</article-title>. <source>Can J Anesth/J Can Anesth</source>. <year>2012</year>;<volume>59</volume>(<issue>7</issue>):<fpage>662</fpage>&#8211;<lpage>669</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12630-012-9716-6</pub-id><pub-id pub-id-type="pmid">22544475</pub-id></mixed-citation></ref><ref id="hpja910-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="hpja910-cit-0004"><string-name name-style="western"><surname>Lee</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Landry</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Buhrmann</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Morley&#8208;Forster</surname><given-names>P</given-names></string-name>. <article-title>The effectiveness of a perioperative smoking cessation program</article-title>. <source>Surv Anesthesiol</source>. <year>2014</year>;<volume>58</volume>(<issue>2</issue>):<fpage>91</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ANE.0b013e318298a6b0</pub-id><pub-id pub-id-type="pmid">23868890</pub-id></mixed-citation></ref><ref id="hpja910-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="hpja910-cit-0005"><string-name name-style="western"><surname>Haddock</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Burrows</surname><given-names>C</given-names></string-name>. <article-title>The role of the nurse in health promotion: an evaluation of a smoking cessation programme in surgical pre&#8208;admission clinics</article-title>. <source>J Adv Nurs</source>. <year>1997</year>;<volume>26</volume>(<issue>6</issue>):<fpage>1098</fpage>&#8211;<lpage>1110</lpage>.<pub-id pub-id-type="pmid">9429959</pub-id></mixed-citation></ref><ref id="hpja910-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="hpja910-cit-0006"><string-name name-style="western"><surname>Webb</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Coward</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Soh</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Waugh</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Parsons</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Lynch</surname><given-names>M</given-names></string-name>, et al. <article-title>Smoking cessation in elective surgical patients offered free nicotine patches at listing: a pilot study</article-title>. <source>Anaesthesia</source>. <year>2020</year>;<volume>75</volume>(<issue>2</issue>):<fpage>171</fpage>&#8211;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1111/anae.14863</pub-id><pub-id pub-id-type="pmid">31646623</pub-id></mixed-citation></ref><ref id="hpja910-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="hpja910-cit-0007"><string-name name-style="western"><surname>Song</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Blyth</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Maskrey</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>McNamara</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Donell</surname><given-names>S</given-names></string-name>. <article-title>Identifying and recruiting smokers for preoperative smoking cessation&#8212;a systematic review of methods reported in published studies</article-title>. <source>Syst Rev</source>. <year>2015</year>;<volume>4</volume>(<issue>1</issue>):<fpage>157</fpage>.<pub-id pub-id-type="pmid">26560883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13643-015-0152-x</pub-id><pub-id pub-id-type="pmcid">PMC4642619</pub-id></mixed-citation></ref><ref id="hpja910-bib-0008"><label>8</label><mixed-citation publication-type="miscellaneous" id="hpja910-cit-0008"><article-title>Pharmaceutical benefits scheme (PBS) | home [Internet]. Pbsgovau</article-title>. <year>2020</year> [cited 4 September 2020]. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.pbs.gov.au/" ext-link-type="uri">https://www.pbs.gov.au/</ext-link></mixed-citation></ref><ref id="hpja910-bib-0009"><label>9</label><mixed-citation publication-type="miscellaneous" id="hpja910-cit-0009"><article-title>Nicotinell patch 21mg 28 day PBS pack [Internet]. Chemistwarehousecomau</article-title>. <year>2020</year> [cited 31 August 2020]. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.chemistwarehouse.com.au/buy/62929/nicotinell-patch-21mg-28-day-pbs-pack" ext-link-type="uri">https://www.chemistwarehouse.com.au/buy/62929/nicotinell&#8208;patch&#8208;21mg&#8208;28&#8208;day&#8208;pbs&#8208;pack</ext-link></mixed-citation></ref><ref id="hpja910-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="hpja910-cit-0010"><string-name name-style="western"><surname>Beaupre</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hammal</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>DeSutter</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Stiegelmar</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Masson</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Finegan</surname><given-names>B</given-names></string-name>. <article-title>Impact of a standardized referral to a community pharmacist&#8208;ledsmoking cessation program before elective jointreplacement surgery</article-title>. <source>Tob Induc Dis</source>. <year>2019</year>;<volume>17</volume>:<fpage>17</fpage>.<pub-id pub-id-type="pmid">31582925</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18332/tid/101600</pub-id><pub-id pub-id-type="pmcid">PMC6751968</pub-id></mixed-citation></ref><ref id="hpja910-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="hpja910-cit-0011"><string-name name-style="western"><surname>Thomas</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Abramson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bonevski</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Poole</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Weeks</surname><given-names>G</given-names></string-name>, et al. <article-title>A pharmacist&#8208;led system&#8208;change smoking cessation intervention for smokers admitted to Australian public hospitals (GIVE UP FOR GOOD): study protocol for a randomised controlled trial</article-title>. <source>Trials</source>. <year>2013</year>;<volume>14</volume>(<issue>1</issue>):<fpage>148</fpage>.<pub-id pub-id-type="pmid">23693155</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1745-6215-14-148</pub-id><pub-id pub-id-type="pmcid">PMC3664596</pub-id></mixed-citation></ref><ref id="hpja910-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="hpja910-cit-0012"><string-name name-style="western"><surname>Li</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Heise</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Reid</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Mullen</surname><given-names>K</given-names></string-name>. <article-title>Implementation of a pharmacist&#8208;led inpatient tobacco cessation intervention in a rehabilitation hospital: a before&#8208;and&#8208;after pilot study</article-title>. <source>Can J Hosp Pharm</source>. <year>2018</year>;<volume>71</volume>(<issue>3</issue>):180&#8208;186.<pub-id pub-id-type="pmcid">PMC6019087</pub-id><pub-id pub-id-type="pmid">29955191</pub-id></mixed-citation></ref><ref id="hpja910-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="hpja910-cit-0013"><string-name name-style="western"><surname>Dent</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Harris</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Noonan</surname><given-names>C</given-names></string-name>. <article-title>Randomized trial assessing the effectiveness of a pharmacist&#8208;delivered program for smoking cessation</article-title>. <source>Ann Pharmacother</source>. <year>2009</year>;<volume>43</volume>(<issue>2</issue>):<fpage>194</fpage>&#8211;<lpage>201</lpage>.<pub-id pub-id-type="pmid">19193572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1345/aph.1L556</pub-id></mixed-citation></ref><ref id="hpja910-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="hpja910-cit-0014"><string-name name-style="western"><surname>deClifford</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>B</given-names></string-name>. <article-title>Evaluation of a pharmacist&#8208;initiated E&#8208;script transcription service for discharged patients</article-title>. <source>J Pharm Pract Res</source>. <year>2009</year>;<volume>39</volume>(<issue>1</issue>):<fpage>39</fpage>&#8211;<lpage>42</lpage>.</mixed-citation></ref><ref id="hpja910-bib-0015"><label>15</label><mixed-citation publication-type="miscellaneous" id="hpja910-cit-0015"><article-title>Training and resources for health services [Internet]. Quitorgau</article-title>. <year>2020</year> [cited 4 September 2020]. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.quit.org.au/resources/health-professionals/training-and-resources-health-services/" ext-link-type="uri">https://www.quit.org.au/resources/health&#8208;professionals/training&#8208;and&#8208;resources&#8208;health&#8208;services/</ext-link></mixed-citation></ref><ref id="hpja910-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="hpja910-cit-0016"><string-name name-style="western"><surname>Benowitz</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Jacob</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ahijevych</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Jarvis</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>LeHouezec</surname><given-names>J</given-names></string-name>, et al. <article-title>Biochemical verification of tobacco use and cessation</article-title>. <source>Nicotine Tob Res</source>. <year>2002</year>;<volume>4</volume>:<fpage>149</fpage>&#8211;<lpage>159</lpage>.<pub-id pub-id-type="pmid">12028847</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14622200210123581</pub-id></mixed-citation></ref><ref id="hpja910-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="hpja910-cit-0017"><string-name name-style="western"><surname>Borland</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Yong</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>O'Connor</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Hyland</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname><given-names>ME</given-names></string-name>. <article-title>The reliability and predictive validity of the heaviness of smoking index and its two components: findings from the international tobacco control four country study</article-title>. <source>Nicotine Tob Res</source>. <year>2010</year>;<volume>12</volume>(<issue>Suppl</issue>):<fpage>S45</fpage>&#8211;<lpage>S50</lpage>.<pub-id pub-id-type="pmid">20889480</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntq038</pub-id><pub-id pub-id-type="pmcid">PMC3307335</pub-id></mixed-citation></ref><ref id="hpja910-bib-0018"><label>18</label><mixed-citation publication-type="miscellaneous" id="hpja910-cit-0018"><collab collab-type="authors">National Cancer Institute D. Modified Version of the Fagerstrom Tolerance Questionnaire (mFTQ)</collab>
. <article-title>BRP | DCCPS/NCI/NIH [Internet]</article-title>. <year>2012</year> [cited 31 August 2020]. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://cancercontrol.cancer.gov" ext-link-type="uri">Cancercontrol.cancer.gov</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://cancercontrol.cancer.gov/brp/tcrb/guide-measures/mftq.html" ext-link-type="uri">https://cancercontrol.cancer.gov/brp/tcrb/guide-measures/mftq.html</ext-link></mixed-citation></ref><ref id="hpja910-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="hpja910-cit-0019"><string-name name-style="western"><surname>Naranjo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Busto</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Sellers</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Sandor</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ruiz</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>E</given-names></string-name>, et al. <article-title>A method for estimating the probability of adverse drug reactions</article-title>. <source>Clin Pharmacol Ther</source>. <year>1981</year>;<volume>30</volume>(<issue>2</issue>):<fpage>239</fpage>&#8211;<lpage>245</lpage>.<pub-id pub-id-type="pmid">7249508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/clpt.1981.154</pub-id></mixed-citation></ref><ref id="hpja910-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="hpja910-cit-0020"><string-name name-style="western"><surname>Gould</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Kelly</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Goldstone</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Gammon</surname><given-names>J</given-names></string-name>. <article-title>Visual analogue scale (VAS)</article-title>. <source>J Clin Nurs</source>. <year>2001</year>;<volume>10</volume>:<fpage>697</fpage>&#8211;<lpage>706</lpage>.<pub-id pub-id-type="pmid">11822520</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2702.2001.00525.x</pub-id></mixed-citation></ref><ref id="hpja910-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="hpja910-cit-0021"><string-name name-style="western"><surname>Newhall</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Suckow</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Spangler</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Brooke</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Schanzer</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>T</given-names></string-name>, et al. <article-title>Impact and duration of brief surgeon&#8208;delivered smoking cessation advice on attitudes regarding nicotine dependence and tobacco harms for patients with peripheral arterial disease</article-title>. <source>Ann Vasc Surg</source>. <year>2017</year>;<volume>38</volume>:<fpage>113</fpage>&#8211;<lpage>121</lpage>.<pub-id pub-id-type="pmid">27521828</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.avsg.2016.06.005</pub-id><pub-id pub-id-type="pmcid">PMC5164838</pub-id></mixed-citation></ref><ref id="hpja910-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="hpja910-cit-0022"><string-name name-style="western"><surname>Warner</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Kadimpat</surname><given-names>S</given-names></string-name>. <article-title>Nicotine lozenges to promote brief preoperative abstinence from smoking: pilot study</article-title>. <source>Clin Health Promot</source>. <year>2012</year>;<volume>2</volume>(<issue>3</issue>):<fpage>85</fpage>&#8211;<lpage>88</lpage>.</mixed-citation></ref><ref id="hpja910-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="hpja910-cit-0023"><string-name name-style="western"><surname>Taylor</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Karahalios</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bramley</surname><given-names>D</given-names></string-name>. <article-title>Long&#8208;term effectiveness of the preoperative smoking cessation programme at Western health</article-title>. <source>ANZ J Surg</source>. <year>2017</year>;<volume>87</volume>(<issue>9</issue>):<fpage>677</fpage>&#8211;<lpage>681</lpage>.<pub-id pub-id-type="pmid">28733996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ans.14113</pub-id></mixed-citation></ref><ref id="hpja910-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="hpja910-cit-0024"><string-name name-style="western"><surname>Young&#8208;Wolff</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Adams</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Fogelberg</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Goldstein</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Preston</surname><given-names>P</given-names></string-name>. <article-title>Evaluation of a pilot perioperative smoking cessation program: a pre&#8208;post study</article-title>. <source>J Surg Res</source>. <year>2019</year>;<volume>237</volume>:<fpage>30</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="pmid">30694789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jss.2018.12.022</pub-id></mixed-citation></ref><ref id="hpja910-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="hpja910-cit-0025"><string-name name-style="western"><surname>Webb</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Coward</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Meanger</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Leong</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>White</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Borland</surname><given-names>R</given-names></string-name>. <article-title>Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial</article-title>. <source>Med J Aust</source>. <year>2022</year>;<volume>216</volume>:<fpage>357</fpage>&#8211;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.5694/mja2.51453</pub-id><pub-id pub-id-type="pmid">35267206</pub-id><pub-id pub-id-type="pmcid">PMC9314866</pub-id></mixed-citation></ref><ref id="hpja910-bib-0026"><label>26</label><mixed-citation publication-type="miscellaneous" id="hpja910-cit-0026"><collab collab-type="authors">RACGP</collab>
. <article-title>Supporting smoking cessation: a guide for health professionals [Internet]. Racgporgau</article-title>. <year>2020</year> [cited 31 August 2020]. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/supporting-smoking-cessation/" ext-link-type="uri">https://www.racgp.org.au/clinical&#8208;resources/clinical&#8208;guidelines/key&#8208;racgp&#8208;guidelines/view&#8208;all&#8208;racgp&#8208;guidelines/supporting&#8208;smoking&#8208;cessation/</ext-link></mixed-citation></ref></ref-list></back></article></pmc-articleset>